iShares Biotechnology ETF (BMV:IBB)

Mexico flag Mexico · Delayed Price · Currency is MXN
2,395.00
0.00 (0.00%)
Last updated: Jul 2, 2025
-4.22%
Assets 5.37B
Expense Ratio 0.45%
PE Ratio 18.58
Dividend (ttm) 7.54
Dividend Yield 0.31%
Ex-Dividend Date n/a
Payout Frequency Quarterly
Payout Ratio 5.85%
1-Year Return -4.22%
Volume n/a
Open 2,395.00
Previous Close 2,395.00
Day's Range 2,395.00 - 2,395.00
52-Week Low 2,300.50
52-Week High 2,955.00
Beta n/a
Holdings 261
Inception Date Feb 5, 2001

About IBB

iShares Biotechnology ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. It invests in public equity markets of the United States. It invests in stocks of companies operating across biotechnology sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE Biotechnology Index, by using representative sampling technique. iShares Biotechnology ETF was formed on February 5, 2001 and is domiciled in the United States.

Asset Class Equity
Category Health Care
Stock Exchange Mexican Stock Exchange
Ticker Symbol IBB
Provider iShares
Index Tracked NYSE Biotechnology (TR)

Performance

IBB had a total return of -4.22% in the past year, including dividends. Since the fund's inception, the average annual return has been 29.23%.

Top 10 Holdings

47.64% of assets
Name Symbol Weight
Vertex Pharmaceuticals Incorporated VRTX 7.76%
Amgen Inc. AMGN 7.73%
Gilead Sciences, Inc. GILD 7.60%
Regeneron Pharmaceuticals, Inc. REGN 6.54%
Alnylam Pharmaceuticals, Inc. ALNY 4.72%
IQVIA Holdings Inc. IQV 3.24%
Mettler-Toledo International Inc. MTD 2.86%
argenx SE ARGX 2.41%
Waters Corporation WAT 2.40%
Natera, Inc. NTRA 2.40%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Mar 18, 2025 2.40925 MXN Mar 21, 2025
Dec 17, 2024 1.25788 MXN Dec 20, 2024
Sep 25, 2024 3.87677 MXN Sep 30, 2024
Mar 21, 2024 2.1107 MXN Mar 27, 2024
Dec 20, 2023 2.11294 MXN Dec 27, 2023
Sep 26, 2023 2.66236 MXN Oct 2, 2023
Full Dividend History